Related by context. All words. (Click for frequent words.) 59 GISSI 59 NHANES III 58 Aggressive Reduction 58 Intervention Trial 57 Meta Analysis 57 Glucosamine Chondroitin Arthritis 57 NCCTG N# 57 Cholesterol Levels SPARCL 56 STRIDE PD 56 longitudinal observational study 56 HCV RESPOND 2 56 Cardiovascular Risk 56 CALERIE 56 Controlled Trial 56 Polyp Prevention Trial 55 Complications Trial 55 Randomized Clinical Trial 55 Prostate Cancer Prevention 55 prospective observational studies 55 NSABP B 55 Carotid Revascularization Endarterectomy vs. 55 Liraglutide Effect 55 IMPACT DCM 55 HYVET 55 RECORD1 54 Coronary Artery Calcium 54 Systematic Review 54 Clinical Outcome 54 Depressive Symptoms 54 Randomized controlled 54 Myocardial Ischemia 54 HCV SPRINT 54 Insulin Therapy 54 Intervention Trial GAIT 54 Diabetes Interventions 54 ORMD 54 EURIDIS 54 Decompensated Heart Failure 53 Lipid Lowering Treatment 53 Framingham Offspring Study 53 Multiethnic Study 53 recurrent venous thromboembolism 53 venous thromboembolic disease 53 NHANES 53 nondiabetic patients 53 Clinical Antipsychotic Trials 53 Spine Patient Outcomes 53 serum leptin 53 Rotavirus Vaccine 53 WHEL 53 ACTIVE W 53 VIRAMUNE XR 53 ALLHAT 53 onset diabetes mellitus 53 multivitamin supplementation 53 Randomized Evaluation 53 Antitumor 53 Glycemic Control 52 CAMMS# 52 Suicidal Ideation 52 Nutrition Examination Surveys NHANES 52 randomized crossover 52 colorectal adenoma 52 atazanavir ritonavir 52 Primary endpoints 52 CARE HF 52 ECASS 52 Stenting Trial CREST 52 Coronary Artery Bypass Graft 52 chromium supplementation 52 CLARITY TIMI 52 Prospective Randomized Trial 52 HPTN 52 dietary questionnaires 52 prospective observational 52 Randomized Controlled Trial 52 glycated hemoglobin 52 randomized controlled trials RCTs 52 SABCS 52 selenium supplementation 52 multicenter randomized controlled 52 multicenter phase 52 Subgroup analysis 52 Chronic Renal Failure 52 HIV seronegative 52 Pharmacologic 52 Treating Chronic 52 MADIT CRT trial 52 longitudinal cohort study 52 riociguat 51 dysglycemia 51 Raloxifene Evaluation MORE 51 OPT CHF 51 ALISTA 51 variceal bleeding 51 Stop Hypertension DASH 51 normotensive 51 hemoglobin A1c HbA1c 51 ATACAND 51 subanalysis 51 NCT# ClinicalTrials.gov 51 β blockers 51 Osteoporotic Fractures 51 Val HeFT 51 Lifestyle Intervention 51 treatment naive genotype 51 AREDS 51 Ventricular Arrhythmias 51 QD dosing 51 Ranolazine 51 Randomized Phase 51 Multicenter Study 51 prucalopride 51 Wisconsin Sleep Cohort 51 meta regression 51 multicenter Phase 51 metaanalysis 51 EVEREST II 51 Improves Outcomes 51 Intervention Trial Evaluating 51 adenotonsillectomy 51 multicenter placebo controlled 51 NHANES #-# 51 Colorectal Adenomas 51 esophageal acid 51 Surgical Treatment 51 unfractionated heparin UFH 51 underwent percutaneous coronary 51 somatostatin analog 50 PLCO 50 Relieve Depression 50 candesartan cilexetil 50 Randomized Study 50 HF ACTION 50 multicenter randomized clinical 50 relapsed MM 50 placebo controlled studies 50 HOPE TOO 50 ENDEAVOR II 50 DCCT 50 HIV HCV coinfected 50 Stop Hypertension DASH diet 50 prospective cohort 50 Ambulatory Blood Pressure 50 Intervention Effectiveness CATIE 50 Thyroid Hormone 50 evaluating mipomersen 50 RE LY 50 Dietary Modification Trial 50 ADVANCE PD 50 Ischaemic 50 AIR2 Trial 50 ALT flares 50 BARI 2D 50 Meta analyzes 50 Hormone Refractory Prostate Cancer 50 TRITON TIMI 50 Hydroxyurea 50 placebo controlled Phase 50 beta blocker therapy 50 GOUT 50 colorectal adenomas 50 Antiviral Therapy 50 prospective observational cohort 50 antiretroviral naive 50 hyperlipidemia hypertension 50 iPrEx 50 PREVENT IV 50 postmenopausal osteoporotic women 50 meta analyzes 50 BCIRG 50 mg BID dose 50 undergone radical prostatectomy 50 undergoing Percutaneous Coronary 50 GISSI HF 50 REVIVE TA 50 RIO Lipids 50 oral rivaroxaban 50 RE LY ® 50 NATRECOR ® 50 dosing cohorts 50 Study Shows Benefits 50 CHAMPION PCI 50 Thrombolysis 50 VADT 50 ExTRACT TIMI 50 Childhood Asthma 50 Alzheimer Disease Cooperative 50 Lowers Risk 49 Asthma Intervention 49 aldosterone antagonists 49 underwent CABG 49 Percutaneous Coronary Intervention 49 Systolic Hypertension 49 Stop Hypertension diet 49 Sleep Disturbances 49 Edge STudy 49 Angiographic 49 phase Ib 49 BENICAR HCT 49 Eye Disease 49 Multicenter AIDS 49 #mg dosing group 49 atherogenic dyslipidemia 49 HNRCA 49 Demonstrates Efficacy 49 Metastatic Prostate Cancer 49 Differential Diagnosis 49 Myocardial Infarction Study 49 MERLIN TIMI 49 T1DM 49 Cardiovascular Risk Reduction 49 underwent radical prostatectomy 49 Stenting Trial 49 Randomised 49 Intervention Effectiveness 49 Study AREDS 49 Sequenced Treatment Alternatives 49 prospective randomized placebo 49 Reduces Mortality 49 diverticular bleeding 49 CALGB # [001] 49 Diabetes ACCORD 49 SORT OUT III 49 Diabetic Foot Ulcer 49 NHANES surveys 49 Childhood Vaccinations 49 dose escalation phase 49 Phase IIA 49 Juvenile Idiopathic Arthritis 49 eculizumab therapy 49 Follicular Lymphoma 49 Cochrane Systematic Review 49 APTIVUS r 49 MADIT II 49 prospective multicentre 49 PRE SURGE 49 ONTARGET 49 retrospective cohort 49 oral antidiabetic medication 49 SPARCL 49 Ischemic Stroke 49 Cancer Prevention ATBC 49 Chronic Heart Failure 49 NATRECOR R 49 Pregnancy Outcomes 49 BiTE antibody MT# 49 Pivotal Trials 49 CRESTOR #mg 49 NEVO RES 49 systolic hypertension 48 atopic disease 48 Valvular Heart Disease 48 TAXUS IV 48 INTERHEART study 48 rFVIIa 48 CATIE AD 48 RE MODEL 48 NICE SUGAR 48 fasting serum 48 Am J Geriatr 48 Scandinavian Simvastatin Survival 48 oral ibandronate 48 Glucosamine chondroitin Arthritis 48 BRIM3 48 Nutritional Status 48 atopic sensitization 48 RIO Diabetes 48 CIMZIA TM certolizumab pegol 48 mg administered orally 48 MEND CABG 48 Acute Ischemic Stroke 48 Women Ischemia Syndrome 48 meta analysis pooling 48 ABCSG 48 PRoFESS 48 Diabetic Kidney Disease 48 Prospective Multicenter 48 serum lipid levels 48 ACOSOG Z# 48 abacavir lamivudine 48 preintervention 48 Psychodynamic Psychotherapy 48 Lipid Lowering 48 mg/m2 dose 48 antihypertensive therapy 48 dyslipidaemia 48 desvenlafaxine succinate 48 Glycemia 48 double blinded placebo 48 serum IGF 48 Multicenter Automatic Defibrillator Implantation 48 antihypertensive medications 48 randomized controlled trial 48 dose titration 48 Multicenter Phase 48 Localized Prostate Cancer 48 Dietary Approaches 48 phase IIIb 48 Multicenter 48 gallstone disease 48 Phase III VISTA 48 Insulin Resistance Atherosclerosis 48 Treatment Outcomes 48 BOLDER II 48 Brain Function 48 DASH Dietary Approaches 48 Valve Replacement 48 abacavir Ziagen 48 hours postdose 48 Sorafenib HCC Assessment 48 Pediatric Asthma 48 multicenter randomized Phase 48 DETROL LA 48 ACCORD Lipid 48 Prospective Randomized 48 Ischemic Heart Disease 47 antidiabetic medication 47 deferiprone 47 nonrandomized 47 CAPRIE 47 Dental Caries 47 atherosclerotic renal artery stenosis 47 Atherosclerosis MESA 47 corrected QT interval 47 inhibitor RG# 47 bolus dose 47 randomized controlled trials 47 SWiTCH 47 oral FTY# 47 aneurysmal subarachnoid hemorrhage 47 meta analysis 47 Platelet Inhibition 47 #mg/day [001] 47 PON1 activity 47 Evaluation WISE 47 TAXUS ATLAS 47 Guidelines Issued 47 multicentre prospective 47 Pressure Ulcer 47 OBPM 47 adenoma recurrence 47 Prostate Lung Colorectal 47 Stop Hypertension 47 ACCORD Eye 47 PROactive 47 AIR CF1 47 Abciximab 47 fasting glucose levels 47 microalbuminuria 47 cinacalcet 47 PROactive Study 47 nonpregnant women 47 IMPROVE HF 47 Acute Myocardial Infarction 47 number NCT# ClinicalTrials.gov 47 eosinophilic asthma 47 designated HVTN 47 Denufosol 47 Rosuvastatin 47 prospectively stratified 47 Myocardial Infarction 47 Clinical Outcomes Utilizing Revascularization 47 LUX Lung 47 thorough QT 47 placebo controlled trials 47 postoperative AF 47 fluvastatin 47 onset atrial fibrillation 47 CORD II 47 COPD exacerbation 47 candesartan 47 chemoradiation therapy 47 Prehypertension 47 NSABP 47 Efficacy Trial 47 ARIXTRA 47 treatment naïve genotype 47 Refractory Angina 47 AIR CF2 47 Digital Mammographic Imaging 47 diabetes mellitus DM 47 Aggressive Behavior 47 strontium ranelate 47 paricalcitol 47 AA Amyloidosis 47 TIMI Study Group 47 zinc supplementation 47 prospectively defined 47 subgroup analyzes 47 Ovarian Cancer Screening 47 Sipuleucel T 47 Systematic Treatment 47 MADIT CRT 47 calcium supplementation 47 DAPT 47 underwent liver transplantation 47 Cardiac Stem Cell 47 Xelox 47 #:#-#,# CrossRef Medline [002] 47 nulliparous women 47 randomized blinded 47 Acute Heart Failure 47 liver biopsies 47 virological response 47 Bioequivalence 47 STEP BD 47 Prehospital 47 Homeostasis 47 WHIMS 47 Early Childhood Longitudinal Study 47 SPIRIT FIRST 47 pyridostigmine 47 Outcome Measures 47 Flovent HFA 47 RCTs 47 cases/# 47 Acute Decompensated Heart Failure 46 blinded randomized 46 Coronary Artery Risk 46 hypercholesterolaemia 46 DASH diet 46 elevated LDL cholesterol 46 recurrent glioblastoma multiforme 46 Neonates 46 randomized controlled clinical trials 46 trials RCTs 46 Recombinant Vaccine 46 ascending dose 46 XIENCE V demonstrated 46 prospectively randomized 46 Epidemiologic Study 46 Therapy Improves 46 morphometric vertebral fractures 46 observational studies 46 Atherosclerosis Risk 46 lipid lowering therapy 46 abdominal laparoscopic surgery 46 Menstrual Pain 46 Left Ventricular Dysfunction 46 Patency 46 symptomatic VTE 46 PRADAXA 46 Corticosteroid 46 folate supplementation 46 ENGAGE AF TIMI 46 atherothrombotic disease 46 Cardiorespiratory 46 histologically confirmed 46 cilostazol 46 Nutrition Examination 46 efavirenz EFV 46 AVERROES 46 FOLPI 46 multicentre 46 Edward Giovannucci 46 randomized multicenter trial 46 II Clinical Trial 46 amoxicillin clavulanate 46 Adjunctive 46 Dialysis Outcomes 46 landmark ATHENA trial 46 HORIZONS AMI 46 Multi Ethnic Study 46 patients undergoing CABG 46 asymptomatic carotid stenosis 46 placebo controlled clinical 46 substudy 46 LEXIVA r 46 Nesiritide 46 TDF FTC 46 ibandronate 46 asthma exacerbations 46 prospective randomized multicenter 46 Framingham Offspring 46 APPRAISE 46 UKPDS 46 Cohort Study 46 HIVNET 46 postexposure prophylaxis 46 Dose escalation 46 paclitaxel eluting stents 46 Environmental Contaminants 46 recurrent VTE 46 prospective nonrandomized 46 Infusion Reactions Severe 46 rt PA 46 EAT Eating 46 Phase IIB 46 ERBITUX therapy 46 CARDIA 46 randomized controlled Phase 46 PROactive study 46 Percutaneous Tibial Nerve Stimulation 46 REYATAZ ritonavir 46 Initiate Lifesaving Treatment 46 Postmenopausal Osteoporosis 46 randomized trials 46 multicenter randomized 46 Preconception 46 quadrivalent HPV vaccine 46 Stress Induced 46 endometriosis ovarian cysts 46 induced hepatotoxicity 46 Parenteral Nutrition 46 reflux disease GERD 46 blinded randomized placebo controlled 46 fosbretabulin 46 NO# [002] 46 Asthma Symptoms 46 Radiation Therapy Oncology 45 multicenter trials 45 Protease Inhibitor 45 pegylated interferon alfa 2b 45 lacosamide 45 CANCIDAS 45 pramlintide metreleptin combination 45 Inhaled Nitric Oxide 45 polyarticular 45 placebo controlled clinical trials 45 Stroke Risk 45 PROCRIT therapy 45 ginkgo biloba extract 45 Screening Trial 45 Phase III Clinical Trial 45 pharmacodynamic effects 45 conducted retrospective cohort 45 postoperative complications 45 journal Atherosclerosis 45 Tyrosine Kinase Inhibitor 45 macrovascular 45 TAXUS ARRIVE 45 Therapeutic Intervention 45 #:#-#,# [003] 45 QUASAR validation study 45 Phase #/#a 45 fenretinide 45 randomized multicenter Phase III 45 EORTC 45 salmeterol fluticasone 45 vildagliptin 45 Young Adults CARDIA 45 oral prednisolone 45 Health Initiative Observational 45 Ocular Hypertension Treatment 45 seroconverted 45 follicular phase 45 relapsing remitting MS RRMS 45 solifenacin 45 Bivalirudin 45 Confirms Efficacy 45 dietary modification 45 pharmacokinetic interaction 45 Pediatric Oncology Branch 45 multicentric 45 hypofractionated radiation 45 PRECiSE 45 Advanced Ovarian Cancer 45 tiotropium 45 Overcoming Addiction 45 TMC# C# 45 TG MV 45 continuously abstinent 45 pharmacokinetic characteristics 45 Dementia Diagnosis 45 gross hematuria 45 actigraphy 45 Quadrivalent 45 Elizabeth Selvin 45 BMI z 45 Swedish Mammography Cohort 45 multiple logistic regression 45 ABC/3TC 45 Biologic Therapy 45 World J Gastroenterol 45 Metabolic Efficiency 45 dose cohort 45 Judith Hochman 45 prostate carcinogenesis 45 Low Incidence 45 androgen suppression 45 multicenter multinational 45 ABSORB trial 45 Communities ARIC Study 45 Telmisartan 45 GYTS 45 pharmacokinetic PK 45 Epithelial Cell 45 FOSRENOL R 45 Enzastaurin 45 Susceptibility Testing 45 shorter telomere length 45 Rakai Uganda 45 Nutrition Examination Survey NHANES 45 F FDG PET 45 label multicenter randomized 45 glomerular filtration rate 45 pegylated liposomal doxorubicin 45 journal Resuscitation 45 TB Vaccine 45 diabetes mellitus 45 assessing T DM1 45 subclinical hypothyroidism 45 ischemic strokes 45 double blinded randomized 45 ezetimibe simvastatin 45 ACCOMPLISH 45 Netherlands Cohort Study 45 retrospective cohort study 45 Relieve Depression STAR 45 Baltimore Longitudinal Study 45 Overactive Bladder OAB 45 fasting glucose 45 antibiotic prophylaxis 45 ritonavir boosted 45 ASCEND HF 45 bazedoxifene conjugated estrogens 45 HbA1c levels 45 suppurative 45 CALGB 45 bosentan 45 VFEND 45 Renal Transplantation 45 placebo controlled Phase III 45 Regression Analysis 45 Phase III placebo controlled 45 intermittent claudication 45 Betaferon ® 45 factorial design 45 buprenorphine naloxone 45 Self Efficacy 45 Severely Obese 45 acute mania 45 liver transplant recipients 45 dose escalation clinical 45 chemoprevention trials 44 ADHF 44 REALITY Trial 44 lipid levels 44 Complications Trial DCCT 44 BoNTA 44 mycophenolate mofetil 44 Partial Nephrectomy 44 Successfully Completes Phase 44 multicentre study 44 clazosentan 44 Acute Coronary Syndromes ACS 44 PREZISTA r 44 recurrent glioma 44 APTIVUS 44 Childhood Immunizations 44 Systematic Reviews 44 Randomized 44 Hepatitis C Virus Infection 44 randomized controlled clinical 44 Trandolapril 44 newer antipsychotic medications 44 journal Contraception 44 aphthous stomatitis 44 National Surgical Adjuvant 44 NLSY 44 Carotid Artery Stenting 44 Left Atrial 44 Neurodevelopment 44 prospective multicenter study 44 HAART regimens 44 Wactawski Wende 44 landmark ATHENA 44 symptomatic BPH 44 retrospectively analyzed 44 colorectal bowel 44 empyema 44 Randomised Study 44 #mg QD [002] 44 liver resection 44 ILLUSTRATE 44 angiotensin receptor blockers 44 Restless Legs 44 fluorouracil leucovorin 44 percutaneous tibial nerve 44 Fibromyalgia Pain 44 AIM HIGH 44 journal Hypertension 44 underwent bariatric surgery 44 NDA Submission 44 SWOG 44 canakinumab 44 ADMIRE HF 44 Paroxysmal 44 rosuvastatin Crestor 44 MiDAS 44 antioxidant supplementation 44 observational cohort 44 Pregnancy Outcome 44 Solid Malignancies 44 sorafenib Nexavar 44 peg interferon 44 Therapy Shows Promise 44 Multiethnic Cohort Study 44 Ovarian PLCO Cancer 44 EMPHASIS HF trial 44 RG# ITMN 44 H2 blocker 44 Pluripotent Stem Cells 44 ENESTnd 44 FMH Wellness Center 44 BLLs 44 Phase Ib II 44 brown baggers #x# 44 mixed hyperlipidemia 44 preoperative PSA 44 Reynolds Risk Score 44 Observational Study 44 anthropometric measurements 44 Interpersonal psychotherapy 44 μg dl 44 oral prednisone 44 Epilepsy Surgery 44 ACTEMRA TM 44 Smallpox Vaccination 44 randomized clinical trials 44 Canadian Multicentre Osteoporosis 44 hemodialysis patients 44 Collaborators Present 44 Kaplan Meier analysis 44 hyperglycaemia 44 PFO migraine 44 pimecrolimus cream 44 Reduces Pain 44 symptom exacerbation 44 ASTEROID 44 MMSE scores 44 ENDEAVOR clinical 44 Conclusions 44 registrational Phase 44 secondary efficacy endpoint 44 multicentre randomized controlled 44 colorectal neoplasms 44 asthma exacerbation 44 serum vitamin D 44 RE LY trial 44 Completes Patient Enrollment 44 external genital lesions 44 Recommends Approval 44 TAXUS VI 44 Herbal Supplements 44 standard chemotherapy regimen 44 Efficacy 44 histologically proven 44 Cardiac Allograft Rejection 44 glatiramer acetate 44 prespecified 44 chewable aspirin 44 invasive candidiasis 44 CLL8 44 Relapse Prevention 44 COREG 44 febrile seizure 44 Myocardial Perfusion 44 Endarterectomy 44 glycated hemoglobin HbA1c 44 carotid endarterectomy CEA 44 prospective longitudinal 44 demonstrated clinically meaningful 44 NEJM 44 venous thrombosis 44 Artificial Liver 44 clopidogrel pretreatment 44 CHD mortality 44 ORACLE MS 44 iNO 44 tibolone 44 GnRH agonists 44 Behavior Change 44 Autism Speaks Autism 44 MAGE A3 ASCI 44 superficial bladder cancer 44 pm Wadsworth Rittman 44 Aggressive Drug Evaluation 44 Chemotherapy Improves 44 Screening Trial DMIST 44 recurrent UTI 44 CAVEATS 44 FIRMAGON ® 43 coronary calcification 43 glucocorticoid induced osteoporosis 43 Scarmeas 43 perinatal outcomes 43 Postnatal 43 Helps Relieve 43 stage IIIB 43 urothelial cancer 43 Renal Cancer 43 intracranial hypertension 43 GENASIS 43 randomized controlled multicenter 43 Caloric Restriction 43 PRTX 43 Nonsurgical 43 Marrow Transplant Research 43 Cochrane Database 43 PERSEUS 43 Chronic Inflammatory 43 adjuvant radiotherapy 43 icatibant 43 stage IIIb IV 43 semiquantitative 43 Adolescent Substance Abuse 43 Cognitively Impaired 43 Randomized trials 43 radioiodine therapy 43 urodynamic 43 Postoperative Pain 43 Treatment Reduces 43 Practical Applications 43 Sleep Disturbance 43 antihypertensive medication 43 COPAXONE R 43 Bacteriological 43 chemoradiotherapy 43 SPIRIT IV 43 dyskinesia PD LID 43 Heart Failure Trial 43 Ispinesib SB # 43 First Patient Enrolled 43 HORIZONS AMI trial 43 postmenopausal hormone therapy 43 dosed intravenously 43 Vulnerable Plaque 43 Acetonide 43 Communities ARIC study 43 impaired glucose tolerance 43 multivariable analysis 43 TRA 2P 43 HCV infected 43 CUSTOM III 43 paroxysmal AF 43 Phase 1a clinical 43 randomisation 43 journal Lancet Neurology 43 placebo controlled 43 Practice Patterns 43 Arterial stiffness 43 Prevent Obesity 43 Phase III multicenter 43 chronic obstructive lung 43 ENDEAVOR IV 43 #mg BID [001] 43 secondary efficacy endpoints 43 non menthol smokers 43 longitudinal studies 43 Trial PCPT 43 undergoing coronary artery 43 multicentre randomized 43 n = 43 elevated triglycerides 43 retrospective observational study 43 quetiapine XR 43 Hazardous Drugs 43 ethambutol 43 ERSPC 43 pharmacokinetics PK 43 acute myocardial infarctions 43 Vascular Inflammation 43 antiretroviral naïve 43 Pharmacotherapy 43 Susceptibility Gene 43 Highly Active Antiretroviral 43 randomized multicenter 43 Resubmission 43 hsCRP 43 aldosterone antagonist 43 SCD HeFT 43 ToGA 43 Occupational Exposure 43 PCI ExTRACT TIMI 43 inflammatory biomarkers 43 CombAT 43 everolimus eluting stents 43 AZILECT R 43 National Epidemiologic Survey 43 Eric Kossoff 43 multicenter Phase III 43 NESARC 43 Apgar scores 43 Antibiotic Therapy 43 anti arrhythmic drug 43 lipoprotein levels 43 pelvic lymphadenectomy 43 CLARITY study 43 TMC# r 43 Anesthetics 43 idraparinux 43 Immunomodulatory 43 Alternative Approaches 43 epidemiologic studies 43 Pre RELAX AHF 43 HRQL 43 Nutrition EPIC 43 Subgroup analyzes 43 Total Hip Replacement 43 inhaled fluticasone 43 polysomnogram 43 Gynecologic Oncology Group 43 COU AA 43 lipid lowering medications 43 mg kg intravenously 43 susceptible isolates 43 randomized 43 pharmacokinetic PK study 43 Phase Ib clinical 43 ACRIN 43 ID NCT# 43 abnormal lipid 43 quinacrine 43 null responder HCV 43 Alpha Tocopherol Beta Carotene 43 AIDS Clinical Trials 43 coronary revascularization 43 lipid lowering drugs 43 Univariate 43 acellular pertussis DTaP 43 BRIM2 43 telmisartan 43 SIMPADICO 43 THIS STUDY 43 iPrEx study 43 Molecular Pathogenesis 43 serum selenium 43 RSD# oral 43 advanced neoplasia 43 tiotropium Spiriva 43 oral naltrexone 43 glycated hemoglobin levels 43 SSRI citalopram 43 darunavir ritonavir 43 PRIMO CABG2 43 BR.# 43 dosage regimens 43 PIX# [002] 43 Slone Epidemiology Center 43 CAPRISA 43 darunavir r 43 lung resection 43 % CI #.#-#.# [008] 43 potential confounders 43 bupropion SR 42 neoadjuvant treatment 42 viral kinetic 42 bullous 42 GAMMAGARD 42 CYPHER Stent 42 Mortality Weekly 42 odanacatib 42 plasma homocysteine 42 collected saliva samples 42 clinico pathological 42 CML CP 42 prazosin 42 dbGaP 42 oral anticoagulation 42 HeFT 42 estrogen progestin therapy 42 Muscle Wasting 42 clinical pharmacology studies 42 carotid artery stenting CAS 42 vitro studies 42 multicenter 42 cerebral microbleeds 42 patients undergoing percutaneous 42 teriflunomide 42 Adolescent Obesity 42 perimenopausal women 42 multicenter randomized placebo controlled 42 multicenter Phase II 42 paclitaxel Taxol R 42 adiponectin levels 42 genital HSV 42 Apolipoprotein E 42 efficacy endpoint 42 label multicenter Phase 42 EMPOWER ™ 42 phase IIa 42 Health Examination Survey 42 Clinical Decision Making 42 PLCO trial 42 genotypic resistance 42 Phase III PREGNANT PROCHIEVE 42 Neurophysiological 42 utero exposure 42 Breast Exams 42 suppressive therapy 42 randomized Phase IIb 42 Heavy Menstrual Bleeding 42 flavanol cocoa 42 Phase 1a 42 CYPHER R stent 42 Cervical Cancer Detection 42 DMSc